Vanguard Group
MIRA icon

Vanguard Group’s MIRA Pharmaceuticals MIRA Stock Holding History

Vanguard Group’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$997K Buy
660,497
+456,854
+224% +$671K ﹤0.01% 3778
2025
Q3 		$277K Buy
203,643
+85,819
+73% +$125K ﹤0.01% 4070
2025
Q2 		$143K Hold
117,824
– – ﹤0.01% 4116
2025
Q1 		$115K Hold
117,824
– – ﹤0.01% 4124
2024
Q4 		$134K Buy
+117,824
New +$154K ﹤0.01% 4145

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Vanguard Group's MIRA Position: Q4 2025 in Review

Vanguard Group increased its MIRA Pharmaceuticals (MIRA) stake by 224% in Q4 2025, buying an estimated $671K and bringing the position to 660,497 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

Vanguard Group first reported a position in MIRA in Q4 2024 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold MIRA as of Q4 2025.

  • Vanguard Group held 660,497 shares of MIRA Pharmaceuticals worth $997K as of Q4 2025.
  • Vanguard Group bought 456,854 MIRA Pharmaceuticals shares in Q4 2025, an estimated $671K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3778 holding.
  • Vanguard Group first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.